Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Black Diamond Therapeutics, Inc. is not a good growth stock. Black Diamond Therapeutics, Inc. is not very popular among insiders. Black Diamond Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
BDTX Fundamental Data by TradingView

News

Wedbush Reiterates Outperform Rating for Black Diamond Therapeutics (NASDAQ:BDTX)
Wedbush Reiterates Outperform Rating for Black Diamond Therapeutics (NASDAQ:BDTX)

Zolmax Black Diamond Therapeutics (NASDAQ:BDTX - Get Free Report)s stock had its "outperform" rating reaffirmed by investment analysts at Wedbush in a research note issued on Tuesday, Benzinga...\n more…

Brokers Set Expectations for Black Diamond Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:BDTX)
Brokers Set Expectations for Black Diamond Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:BDTX)

Ticker Report Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - Equities researchers at HC Wainwright raised their Q3 2024 EPS estimates for shares of Black Diamond Therapeutics in a research note...\n more…

Black Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Reaffirmed by HC Wainwright
Black Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Reaffirmed by HC Wainwright

Zolmax Black Diamond Therapeutics (NASDAQ:BDTX - Get Free Report)s stock had its "buy" rating reiterated by research analysts at HC Wainwright in a report released on Wednesday, Benzinga reports...\n more…

SG Americas Securities LLC Invests $108,000 in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)
SG Americas Securities LLC Invests $108,000 in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)

Ticker Report SG Americas Securities LLC purchased a new stake in shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F...\n more…

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decrease in Short Interest
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decrease in Short Interest

Ticker Report Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling...\n more…

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Significant Drop in Short Interest
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Significant Drop in Short Interest

Zolmax Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totalling...\n more…